We are live on
!
Find out more
ADMA Biologics
ADMA
ADMA
130 hedge funds and large institutions have $315M invested in ADMA Biologics in 2022 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 43 increasing their positions, 33 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
296% more call options, than puts
Call options by funds: $3.82M | Put options by funds: $965K
155% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 11
42% more capital invested
Capital invested by funds: $223M → $315M (+$92.6M)
30% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 33
15% more funds holding
Funds holding: 113 → 130 (+17)
5.37% more ownership
Funds ownership: 60.72% → 66.09% (+5.4%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
130
Holders Change
+17
Holders Change %
+15.04%
% of All Funds
2.24%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
28
Increased
43
Reduced
33
Closed
11
Calls
$3.82M
Puts
$965K
Net Calls
+$2.86M
Net Calls Change
+$2M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$15.5M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$7.46M |
| 3 |
FAM
Fred Alger Management
New York
|
+$6.87M |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$5.25M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$3.7M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$9.99M |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$5.97M |
| 3 |
BFM
Boothbay Fund Management
New York
|
-$5.37M |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$4.8M |
| 5 |
ACM
Altium Capital Management
New York
|
-$2.68M |
